propylene glycol Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
PROPYLENE GLYCOL is a component of SYSTANE® Lubricant. It is used for the temporary relief of burning and irritation due to dryness of the eye.   NCATS

Chemistry

  • SMILES: CC(O)CO
  • InChIKey: DNIAPMSPPWPWGF-UHFFFAOYSA-N
  • Mol. Mass: 76.0944
  • ALogP: -0.64
  • ChEMBL Molecule:
    propylene glycol  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)

United States

$1.0050 - $8.2450
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

1,2-dihydroxypropane | 1,2-propanediol | 1,2-propylene glycol | 1,2-propylenglykol | 146-9251 cream | 2-hydroxypropanol | centella asiatica | cetaphil | e1520 | e490 | isopropylene glycol | methylethylene glycol | methylethyl glycol | methyl glycol | monopropylene glycol | ppd | propane-1,2-diol | propylene glycol | propylene glycol cefatrizine | sentry propylene glycol | sirlene | α-propyleneglycol

Organizations (38)

Research & Development (38)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (22)

Approved Indications (1)


 

Dry Eye Syndromes (approved 2003)

Experimental Indications - Clinical Trial Phases 1-4 (22)


 

Acne Vulgaris (Phase 4)

Allergy and Immunology (Phase 1)

Blood Loss, Surgical (Phase 3)

Cataract (Phase 4)

Constipation (Phase 2)

Contact Lenses (Phase 4)

Corneal Diseases (Phase 4)

Dermatitis, Atopic (Phase 2)

Diabetic Neuropathies (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Dry Eye Syndromes (Phase 4)

Hair (Phase 4)

Healthy Volunteers (Phase 4)

Ichthyosis Vulgaris (Phase 2)

Keratosis, Actinic (Phase 3)

Melanosis (Phase 4)

Neuralgia (Phase 2)

Ophthalmology (Phase 4)

Poisoning (Phase 2)

Pruritus (Phase 4)

Tears (Phase 1)

Tooth Abnormalities (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 45
  • # of Trial Organizations: 38

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue